News & HighlightsNews
A compound that stops cells from making protein factories could lead to new antifungal drugs
Tiny, abundant biological factories, known as ribosomes, produce the cell’s most fundamental building material: protein. If ribosomes don’t work, cells can’t divide—and this can be an advantage for scientists seeking to develop drugs that target invading organisms, such as pathogenic fungi. ...
Four Rockefeller scientists named 2016 HHMI Faculty Scholars
Four Rockefeller University scientists—Daniel Kronauer, Luciano Marraffini, Agata Smogorzewska, and Sohail Tavazoie—have been named Howard Hughes Medical Institute Faculty Scholars. The Faculty Scholars program, a new collaboration between HHMI, the Simons Foundation, and the Bill & Melinda Gate...
Researchers find combined effects of two genes responsible for premature skull fusion in infants
During the first year of life, the human brain doubles in size, and continues expanding through adolescence. The loosely connected bony plates of the young skull accommodate this growth. But sometimes, these bones fuse too early, a disorder known as craniosynostosis. This disorder can produce fac...
Four postdocs honored with 2016 Tri-Institutional Breakout Awards
NEW YORK, NY—Four young life scientists from Memorial Sloan Kettering Cancer Center, The Rockefeller University, and Weill Cornell Medicine are the winners of the 2016 Tri-Institutional Breakout Awards for Junior Investigators. The awards, established last year by three winners of the 2013 Breakt...
New antibody drug continues to show promise for treatment of HIV
Great strides have been made in recent years to develop treatment options for HIV, and the disease can now be controlled with anti-retroviral drugs. But a cure remains elusive and current medications have limitations: they must be taken daily, for life, and can cause long-term complications. Now,...
Postdoc John Maciejowski wins 2016 Regeneron Prize for Creative Innovation
John Maciejowski, a postdoctoral fellow in Titia de Lange’s Laboratory of Cell Biology and Genetics, has received the 2016 Regeneron Prize for Creative Innovation. The award, given by Regeneron Pharmaceuticals, Inc., recognizes innovative young scientists based on proposals they submit that have ...
Michel C. Nussenzweig honored with the 2016 Robert Koch Award
Michel C. Nussenzweig, Zanvil A. Cohn and Ralph M. Steinman Professor and head of the Laboratory of Molecular Immunology, has won the 2016 Robert Koch Award. Nussenzweig will share the €100,000 prize, given by the Robert Koch Foundation of Germany, with Alberto Mantovani from Humanitas University...
Researchers uncover how “silent” genetic changes drive cancer
At any given moment, the human genome spells out thousands of genetic words telling our cells which proteins to make. Each word is read by a molecule known as a tRNA. “We’ve long thought of these molecules as little more than middle men participating in the process of translating proteins...
35 labs and counting: How the Robertson Therapeutic Development Fund speeds translational research at Rockefeller
by Alexandra MacWade, assistant editor Developing a new medical product is a complex, high-risk endeavor. Of the thousands of clinically promising concepts scientists formulate each year, only a small fraction move beyond the lab. The Robertson TDF was created to advance work that has gone beyon...
Scientists find evidence that cancer can arise from changes in the proteins that package DNA
A mutation that affects the proteins that package DNA—without changing the DNA itself—can cause a rare form of cancer, according to new findings in this week’s Science from researchers at Rockefeller University. The mutation is present in histones, the protein scaffolding around which DNA w...
View
View